Search

Brian Lestini Phones & Addresses

  • 325 Chester Ave, Moorestown, NJ 08057 (856) 638-5926
  • 215 Manhattan Ave APT 2, Union City, NJ 07087 (201) 290-2897
  • 215 Manhattan Ave, Union City, NJ 07087
  • Jersey City, NJ
  • 4381 Manayunk Ave, Philadelphia, PA 19128
  • 2399 Euclid Heights Blvd, Cleveland, OH 44106 (216) 229-2910
  • Woodsfield, OH
  • Los Angeles, CA
  • 345 E Main St, Moorestown, NJ 08057

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Ranks

Certificate: American Board of Pediatrics Certification in Pediatrics

Professional Records

License Records

Brian Joseph Lestini

Address:
Moorestown, NJ 08057
License #:
MD428596 - Active
Category:
Medicine
Type:
Medical Physician and Surgeon

Brian Joseph Lestini

Address:
Philadelphia, PA 19104
License #:
MT187693 - Expired
Category:
Medicine
Type:
Graduate Medical Trainee

Medicine Doctors

Brian Lestini Photo 1

Brian Joseph Lestini, Philadelphia PA

View page
Specialties:
Pediatrics
Pediatric Hematology-Oncology
Work:
Childrens Anesthesiology Assoc
324 S 34Th St, Philadelphia, PA 19104
Education:
Case Western Reserve University(2003)
Brian Lestini Photo 2

Brian Lestini, Philadelphia PA

View page
Specialties:
Pediatric Hematologist / Oncologist
Address:
3535 Market St, Philadelphia, PA 19104
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Brian Joseph Lestini
Brian Lestini MD
Pediatric Oncologist · Pediatrician
324 S 34 St, Philadelphia, PA 19104
(215) 590-1000

Publications

Us Patents

Combination Therapy

View page
US Patent:
20120148533, Jun 14, 2012
Filed:
Dec 7, 2011
Appl. No.:
13/313042
Inventors:
Kapil Dhingra - Sparta NJ, US
Brian Higgins - Fresh Meadows NY, US
Kenneth Kolinsky - Bloomingdale NJ, US
Richard J. Lee - New York NY, US
Brian Lestini - Union City NJ, US
Kathryn Packman - Bloomfield NJ, US
Fei Su - Paramus NJ, US
International Classification:
A61K 38/21
A61P 35/00
US Classification:
424 857, 424 854
Abstract:
The present invention relates to a combination therapy of propane-1-sulfonic acid{3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl-2,4-difluoro-phenyl]-amide}, or a pharmaceutically acceptable salt thereof, and an interferon for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. In particular, the present invention relates to such a therapy wherein the interferon is peginterferon alfa-2a and the disorder is melanoma containing the V600E b-Raf mutation.

Combination Therapy

View page
US Patent:
20120045433, Feb 23, 2012
Filed:
Aug 10, 2011
Appl. No.:
13/206548
Inventors:
Kapil Dhingra - Sparta NJ, US
Brian Higgins - Fresh Meadows NY, US
Kenneth Kolinsky - Bloomingdale NJ, US
Richard J. Lee - Montclair NJ, US
Brian Lestini - Union City NJ, US
Kathryn Packman - Bloomfield NJ, US
Fei Su - Paramus NJ, US
International Classification:
A61K 31/437
A61K 39/395
A61P 35/00
A61K 31/4545
US Classification:
4241331, 514300, 514280
Abstract:
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an topoisomerase inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. In particular, the present invention relates to such a therapy wherein the topoisomerase inhibitor is irinotecan, or a pharmaceutically acceptable salt thereof, and the disorder is colorectal cancer involving a tumor comprising b-Raf having the V600E mutation.

Combination Therapy

View page
US Patent:
20120045434, Feb 23, 2012
Filed:
Aug 10, 2011
Appl. No.:
13/206557
Inventors:
Kapil Dhingra - Sparta NJ, US
Brian Higgins - Fresh Meadows NY, US
Kenneth Kolinsky - Bloomingdale NJ, US
Richard J. Lee - Montclair NJ, US
Brian Lestini - Union City NJ, US
Kathryn Packman - Bloomfield NJ, US
Fei Su - Paramus NJ, US
International Classification:
A61K 39/395
A61P 35/00
A61K 31/4738
A61K 31/437
A61K 31/517
US Classification:
4241331, 514300, 5142664, 514283
Abstract:
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.

Combination Therapy

View page
US Patent:
20160256529, Sep 8, 2016
Filed:
Mar 7, 2016
Appl. No.:
15/063227
Inventors:
- Nutley NJ, US
Brian HIGGINS - Fresh Meadows NY, US
Kenneth KOLINSKY - Bloomingdale NJ, US
Richard J. LEE - New York NY, US
Brian LESTINI - Union City NJ, US
Kathryn PACKMAN - Bloomfield NJ, US
Fei SU - Paramus NJ, US
Assignee:
HOFFMANN-LA ROCHE INC. - Nutley CA
International Classification:
A61K 38/21
A61K 31/437
Abstract:
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo [2,3-b] pyridine-3-carbonyl-2,4-difluoro-phenyl]-amide}, or a pharmaceutically acceptable salt thereof, and an interferon for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. In particular, the present invention relates to such a therapy wherein the interferon is peginterferon alfa-2a and the disorder is melanoma containing the V600E b-Raf mutation.
Brian J Lestini from Moorestown, NJ, age ~51 Get Report